Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.

Saved in:
Bibliographic Details
Title: Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases.
Authors: Raptis CE; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Berger CT; University Center for Immunology and Immunization Clinic, University Hospital Basel, Basel, Switzerland.; Translational Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland., Ciurea A; Department of Rheumatology, Zurich University Hospital, University of Zurich, Zurich, Switzerland., Andrey DO; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Polysopoulos C; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Lescuyer P; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland., Maletic T; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Riek M; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Scherer A; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., von Loga I; SCQM Foundation (Swiss Clinical Quality Management in Rheumatic Diseases), Zurich, Switzerland., Safford J; RheumaCura Foundation, Bern, Switzerland., Lauper K; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland., Möller B; Division of Rheumatology and Immunology, Inselspital, Bern University Hospital, Bern, Switzerland., Vuilleumier N; Laboratory Medicine Division, Geneva University Hospitals, Geneva, Switzerland.; Faculty of Medicine, University of Geneva, Geneva, Switzerland., Finckh A; Faculty of Medicine, University of Geneva, Geneva, Switzerland.; Division of Rheumatology, Geneva University Hospitals, Geneva, Switzerland., Rubbert-Roth A; Division of Rheumatology and Immunology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.
Source: Frontiers in immunology [Front Immunol] 2022 Oct 13; Vol. 13, pp. 1016927. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2022.1016927